Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
13-Jul-2026 | 568 | 571 | 557.6 | 564.7 | 10,319 | 4,85,58,046.6 | 39,371 |
14-Jul-2026 | 564 | 564.7 | 551.15 | 559.2 | 15,860 | 9,29,10,013.95 | 1,04,178 |
15-Jul-2026 | 563 | 585.4 | 559.7 | 571.65 | 33,561 | 40,44,69,972.15 | 3,95,288 |
16-Jul-2026 | 577.95 | 584 | 572 | 578.45 | 8,382 | 8,72,08,861.85 | 78,465 |
17-Jul-2026 | 580.85 | 583.35 | 540.05 | 545.3 | 18,545 | 18,07,77,618.95 | 1,69,216 |
20-Jul-2026 | 542.9 | 577 | 542.85 | 573.75 | 19,393 | 20,75,13,253.45 | 1,45,619 |
21-Jul-2026 | 572 | 573 | 562.5 | 568.8 | 7,978 | 5,27,90,552.5 | 44,632 |
22-Jul-2026 | 569 | 579.25 | 560.5 | 570.1 | 7,409 | 6,75,63,428.05 | 51,762 |
23-Jul-2026 | 572 | 575.7 | 563.4 | 567.45 | 8,527 | 11,22,07,961.15 | 1,40,460 |
24-Jul-2026 | 569.9 | 575 | 565.85 | 570.25 | 9,570 | 18,34,58,607.3 | 2,46,537 |
27-Jul-2026 | 574.95 | 594 | 574.95 | 577.35 | 18,566 | 20,77,93,369 | 2,11,317 |
28-Jul-2026 | 582 | 593 | 579.75 | 585.5 | 19,471 | 21,17,59,206.65 | 2,33,300 |
29-Jul-2026 | 585.5 | 598.8 | 583.05 | 591.6 | 18,856 | 27,71,11,132.05 | 2,90,839 |
30-Jul-2026 | 592.2 | 609.05 | 581.6 | 585.2 | 22,902 | 27,35,19,279.9 | 1,87,026 |
31-Jul-2026 | 585.2 | 586.15 | 567.6 | 582.45 | 25,397 | 18,77,00,413.35 | 1,75,643 |
03-Aug-2026 | 584.95 | 605 | 584.7 | 596.45 | 11,869 | 11,01,36,946.45 | 84,643 |
04-Aug-2026 | 597.35 | 597.35 | 581.4 | 584.5 | 9,796 | 9,72,98,488.55 | 1,03,921 |
05-Aug-2026 | 590 | 592 | 571.3 | 576.75 | 13,103 | 13,73,12,164.4 | 93,316 |
06-Aug-2026 | 582.35 | 588.65 | 551.1 | 564.6 | 10,390 | 12,48,86,075.7 | 1,18,813 |
07-Aug-2026 | 560 | 572.6 | 559.25 | 563.2 | 11,231 | 7,45,83,019.9 | 69,850 |
10-Aug-2026 | 565 | 574.9 | 559.3 | 572.65 | 8,206 | 8,14,63,205.35 | 91,228 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
